Kindred Biosciences
NASDAQ:KINKindred Biosciences, Inc. is a development-stage biopharmaceutical company, which focuses on saving and improving the lives of pets. The company was founded by Richard Chin and Denise M. Bevers on September 25, 2012 and is headquartered in Burlingame, CA.
Kezar Life Sciences
NASDAQ:KZRKezar Life Sciences, Inc., a clinical-stage biotechnology company, engages in the discovery and development of novel small molecule therapeutics to treat unmet needs in immune-mediated diseases and cancer in the United States. The company's lead product candidate is zetomipzomib (KZR-616), a selective immunoproteasome inhibitor that is in Phase 2b clinical trials for various indications, including lupus nephritis, dermatomyositis, and polymyositis; Phase 1b clinical trials in systemic lupus erythematosus; and completed Phase 2a clinical trials in lupus nephritis. Its preclinical products include KZR-261, a novel first-in-class protein secretion inhibitor for the treatment of tumors resistant to traditional chemotherapeutics. Kezar Life Sciences, Inc. was incorporated in 2015 and is headquartered in South San Francisco, California.
Silver Bull Resources
TSE:SVBSilver Bull Resources, Inc., an exploration stage company, acquires, explores, and develops mineral properties in Mexico, Kazakhstan, and Canada. The company primarily explores for silver, lead, copper, and zinc deposits, as well as gold. Its principal project is the Sierra Mojada property comprising 20 concessions covering an area of 6,496 hectares located in Coahuila, Mexico. The company was formerly known as Metalline Mining Company and changed its name to Silver Bull Resources, Inc. in April 2011. Silver Bull Resources, Inc. was incorporated in 1993 and is based in Vancouver, Canada.